Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation of Oxidative Stress in Appendectomy - Open Versus Laparoscopic in Childhood and Adolescence (OSAE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03723642
Recruitment Status : Recruiting
First Posted : October 29, 2018
Last Update Posted : July 15, 2020
Sponsor:
Collaborators:
University of Rostock
Graz University of Technology
Information provided by (Responsible Party):
Warncke Gert, MD, Medical University of Graz

Brief Summary:
In the planned prospective randomized study, oxidative stress will be investigated by analyzing volatile organic compounds in the exhaled air in children. Children who have undergone open versus laparoscopic surgery for appendicitis will be compared. A better understanding of the effects of the surgical technique could be a prerequisite for an optimized surgical setting. It could also lead to recommendations for pre- or perioperatively antioxidative agents.

Condition or disease Intervention/treatment Phase
Appendicitis Acute Diagnostic Test: Initial serum malondialdehyde level Diagnostic Test: Final serum malondialdehyde level Diagnostic Test: Initial differential white blood cell count Diagnostic Test: Final differential white blood cell count Diagnostic Test: Initial c-reactive protein serum level Diagnostic Test: Final c-reactive protein serum level Diagnostic Test: Initial VOC Diagnostic Test: VOC 5min Diagnostic Test: VOC 15min Diagnostic Test: VOC 30min Diagnostic Test: VOC 45min Diagnostic Test: Final VOC Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: 40 patients aged 6-18 years suffering from acute appendicitis are to be included. These are divided into 2 groups. Group 1 (n = 20) with laparoscopic and group 2 (n = 20) with open appendectomy.
Masking: Single (Participant)
Masking Description: After obtaining written informed consent from patients/legal guardians the patients will be randomized 1:1 to one of the two surgical techniques. Randomization is carried out using the web-based "Randomizer for Clinical Trials" program at the Institute of Medical Informatics, Statistics and Documentation at the Medical University of Graz (www.randomizer.at).
Primary Purpose: Basic Science
Official Title: Investigation of Oxidative Stress - Open Appendectomy (OAE) Versus Laparoscopic Appendectomy (LAE) in Childhood and Adolescence - A Pilot Study
Actual Study Start Date : October 2, 2019
Estimated Primary Completion Date : October 1, 2020
Estimated Study Completion Date : December 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Appendicitis

Arm Intervention/treatment
Active Comparator: OAE group
All patients will undergo measurements of oxydative stress (initial serum malondialdehyde level and final serum malondialdehyde level), White blood cell count (initial differential white blood cell count and final differential white blood cell count), c-reactive protein measurements (initial c-reactive protein serum level and final c-reactive protein serum level) as well as volatile organic compound (VOC) sampling (initial VOC, VOC 5min, VOC 15min, VOC 30min, VOC 45min and final VOC).
Diagnostic Test: Initial serum malondialdehyde level

Blood sample (0.4ml) will be obtained within 5 minutes before induction of general anaesthesia.

Samples will be obtained in both groups (LAE and OAE)


Diagnostic Test: Final serum malondialdehyde level
Blood sample (0.4ml) will be obtained within 5 minutes after wound closure. Samples will be obtained in both groups (LAE and OAE)

Diagnostic Test: Initial differential white blood cell count

Differential blood counts (microscopic) will be obtained during pre-operative routine work-up.

Samples will be obtained in both groups (LAE and OAE).


Diagnostic Test: Final differential white blood cell count

Differential blood counts (microscopic) will be obtained 24h after the first sample (Initial differential blood count).

Samples will be obtained in both groups (LAE and OAE).


Diagnostic Test: Initial c-reactive protein serum level

C-reactive protein levels will be obtained during pre-operative routine work-up.

Samples will be obtained in both groups (LAE and OAE).


Diagnostic Test: Final c-reactive protein serum level

C-reactive protein levels will be obtained 24h after the first sample (initial c-reactive protein level).

Samples will be obtained in both groups (LAE and OAE).


Diagnostic Test: Initial VOC
Volatile organic compound sampling (2 samples within 5 minutes) within 10 minutes before induction of general anesthesia

Diagnostic Test: VOC 5min
Volatile organic compound sampling (2 samples within5 minutes) within 5 minutes after endotracheal intubation before skin incision.

Diagnostic Test: VOC 15min
Volatile organic compound sampling (2 samples within 5 minutes) 15 minutes after skin incision.

Diagnostic Test: VOC 30min
Volatile organic compound sampling (2 samples within 5 minutes) 30 minutes after skin incision.

Diagnostic Test: VOC 45min
Volatile organic compound sampling (2 samples within 5 minutes) 45 minutes after skin incision.

Diagnostic Test: Final VOC
Volatile organic compound sampling (2 samples within 5 minutes) within 5 minutes after skin closure.

Active Comparator: LAE group
All patients will undergo measurements of oxydative stress (initial serum malondialdehyde level and final serum malondialdehyde level), White blood cell count (initial differential white blood cell count and final differential white blood cell count), c-reactive protein measurements (initial c-reactive protein serum level and final c-reactive protein serum level) as well as volatile organic compound (VOC) sampling (initial VOC, VOC 5min, VOC 15min, VOC 30min, VOC 45min and final VOC).
Diagnostic Test: Initial serum malondialdehyde level

Blood sample (0.4ml) will be obtained within 5 minutes before induction of general anaesthesia.

Samples will be obtained in both groups (LAE and OAE)


Diagnostic Test: Final serum malondialdehyde level
Blood sample (0.4ml) will be obtained within 5 minutes after wound closure. Samples will be obtained in both groups (LAE and OAE)

Diagnostic Test: Initial differential white blood cell count

Differential blood counts (microscopic) will be obtained during pre-operative routine work-up.

Samples will be obtained in both groups (LAE and OAE).


Diagnostic Test: Final differential white blood cell count

Differential blood counts (microscopic) will be obtained 24h after the first sample (Initial differential blood count).

Samples will be obtained in both groups (LAE and OAE).


Diagnostic Test: Initial c-reactive protein serum level

C-reactive protein levels will be obtained during pre-operative routine work-up.

Samples will be obtained in both groups (LAE and OAE).


Diagnostic Test: Final c-reactive protein serum level

C-reactive protein levels will be obtained 24h after the first sample (initial c-reactive protein level).

Samples will be obtained in both groups (LAE and OAE).


Diagnostic Test: Initial VOC
Volatile organic compound sampling (2 samples within 5 minutes) within 10 minutes before induction of general anesthesia

Diagnostic Test: VOC 5min
Volatile organic compound sampling (2 samples within5 minutes) within 5 minutes after endotracheal intubation before skin incision.

Diagnostic Test: VOC 15min
Volatile organic compound sampling (2 samples within 5 minutes) 15 minutes after skin incision.

Diagnostic Test: VOC 30min
Volatile organic compound sampling (2 samples within 5 minutes) 30 minutes after skin incision.

Diagnostic Test: VOC 45min
Volatile organic compound sampling (2 samples within 5 minutes) 45 minutes after skin incision.

Diagnostic Test: Final VOC
Volatile organic compound sampling (2 samples within 5 minutes) within 5 minutes after skin closure.




Primary Outcome Measures :
  1. Are volatile respiratory gas markers for oxidative stress (such as pentanes, isoprenes) dependent on the surgical method (open versus laparoscopic appendectomy)? [ Time Frame: 1 year ]
    We investigate the respiratory volatile organic compounds before, during and at the end of surgery and compare the respiratory gas profiles of the two groups open versus laparoscopic appendectomy.


Secondary Outcome Measures :
  1. Alterations of serum malondialdehyde serum levels. [ Time Frame: 1 year ]
    The changes of the serum marker for oxidative stress MDH before and after surgery will be investigated and the changes in open versus laparoscopic appendectomy will be compared. One sample will be taken preoperatively and one sample postoperatively.

  2. Alterations of inflammation markers. [ Time Frame: 1 year ]
    The changes of the serum inflammation markers before and after surgery will be investigated and the changes in open versus laparoscopic appendectomy will be compared.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age from 6-18 years
  • reliable diagnosis of acute appendicitis
  • surgical therapy using open/laparoscopic surgical technique
  • given approval

Exclusion Criteria:

  • Age not between 6 and 18 years
  • chronic underlying disease/autoimmune disease
  • complicated appendicitis (perforation, consecutive purulent peritonitis, abscess formation)
  • infection outside acute appendicitis
  • SIRS
  • taking medications containing the cytochrome P450 (CYP) system affect including cortisone
  • impaired liver function
  • unaccepted consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03723642


Contacts
Layout table for location contacts
Contact: Gert Warncke, MD 01143316385 ext 81153 gert.warncke@medunigraz.at
Contact: Christoph Castellani, MD 01143316385 ext 80217 christoph.castellani@medunigraz.at

Locations
Layout table for location information
Austria
Department of Paediatric and Adolescent Surgery Recruiting
Graz, Austria, 8036
Sponsors and Collaborators
Medical University of Graz
University of Rostock
Graz University of Technology
Investigators
Layout table for investigator information
Study Director: Holger Till, MD Department of Pediatric and Adolescent Surgery, Medical University of Graz
Principal Investigator: Gert Warncke, MD Department of Pediatric and Adolescent Medicine, Medical University of Graz
Publications of Results:

Other Publications:

Layout table for additonal information
Responsible Party: Warncke Gert, MD, Principal Investigator, Medical University of Graz
ClinicalTrials.gov Identifier: NCT03723642    
Other Study ID Numbers: 30-120 ex 17/18
First Posted: October 29, 2018    Key Record Dates
Last Update Posted: July 15, 2020
Last Verified: July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Warncke Gert, MD, Medical University of Graz:
acute appendicitis
volatile organic compounds
oxidative stress
laparoscopic appendectomy
open appendectomy
Additional relevant MeSH terms:
Layout table for MeSH terms
Appendicitis
Intraabdominal Infections
Infections
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Cecal Diseases
Intestinal Diseases